DPIIT recognised startup Government of India
Startup India
Intergene Biosciences Private Limited
Intergene Biosciences Private Limited - chemicals in Bangalore, Karnataka, India. Directors, charges & compliance details.
Revenue · FY 2025
₹8.21 Lakh
▲ 55% YoY
Net loss · FY 2025
₹3.94 Lakh
Net margin -48.1%
EBITDA · FY 2025
-₹4.57 Lakh
EBITDA margin -55.7%
Authorised capital
₹1.1 Lakh
Registered with MCA
Paid-up capital
₹1.03 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
3
As per MCA filings
Brands
1
Associated brands
About Intergene Biosciences Private Limited
Data last updated:
Intergene Biosciences Private Limited is a private limited company based in Bangalore, Karnataka, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 06 April 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24230KA2021PTC146156.
The company has an authorised share capital of ₹1.1 Lakh and a paid-up capital of ₹1.03 Lakh. It is led by directors including Ganessin Aravind and Uma Thiagarajan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No. 210 Second Floor I Phase I Main Road Kengeri Satellite Town, Bangalore, Karnataka, India – 560060.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.21 Lakh, a growth of 55% compared to the previous year. For the same year it recorded a net loss of ₹3.94 Lakh (net margin -48.1%) and EBITDA of -₹4.57 Lakh (EBITDA margin -55.7%). Revenue has grown at a compounded annual rate (CAGR) of 90% over three years.
The company is associated with 1 brand: Intergene Biosciences.
Intergene Biosciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0074828).
Company details
CIN U24230KA2021PTC146156
Registration Number 146156
Incorporation Date 06 April 2021
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-KR-03-0074828
Recognitions & Rankings of Intergene Biosciences
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-KR-03-0074828
Contact details
Intergene Biosciences Private Limited's registered office is in Bangalore, Karnataka.
- Registered AddressNo. 210 Second Floor I Phase I Main Road Kengeri Satellite Town, Bangalore, Karnataka, India – 560060
- IndustryChemicals, Manufacturing, Other Chemical Product
Comprehensive company report
Intergene Biosciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Intergene Biosciences operates one associated brand: Intergene Biosciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides genetic sequencing, analysis, and R&D support for life sciences professionals. | intergenebio.com |
Business activity
The main business activity of Intergene Biosciences is professional, scientific and technical activities. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, scientific and technical activities | 72 | Scientific research and development |
To see the full business activity and turnover split of Intergene Biosciences Private Limited, buy the company report.
Financials of Intergene Biosciences Private Limited
FY 2025 filings availableIntergene Biosciences Private Limited reported revenue of ₹8.21 Lakh (up 55% YoY) for FY 2025.
Revenue · FY 2025
₹8.21 Lakh ▲ 55%
Net loss · FY 2025
₹3.94 Lakh margin -48.1%
EBITDA · FY 2025
-₹4.57 Lakh margin -55.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 55%
3 years · compounded
▲ 90%
EBITDA CAGR growth
3 years · compounded
▼ 122%
Revenue has grown at a compounded annual rate (CAGR) of 90% over three years, including 55% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹4.57 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹3.94 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -55.7% | |||
| Net Profit Margin | -48.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Intergene Biosciences Private Limited, buy the company report.
Board of directors of Intergene Biosciences Private Limited
Intergene Biosciences has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ganessin Aravind Also directs: Dextrose Technologies Private Limited | Director | 06 Apr 2021 | 5 Years 6 Months | Current |
| Uma Thiagarajan | Director | 06 Apr 2021 | 5 Years 6 Months | Current |
| Aniruddha Maram | Director | 25 Apr 2024 | 2 Years 6 Months | Current |
Legal cases
No court or tribunal cases involving Intergene Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Intergene Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Intergene Biosciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Intergene Biosciences Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Aniruddha Maram was appointed as Director on 25 Apr 2024.
AGM
Intergene Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Intergene Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Appointed
Aniruddha Maram was appointed as Director.
Appointed
Ganessin Aravind was appointed as Director.
Appointed
Uma Thiagarajan was appointed as Director.
Incorporation
06 Apr 2021
Intergene Biosciences Private Limited was registered on 06 Apr 2021 with Roc Bangalore & aged 5 years 6 months as per MCA records.
Frequently asked questions
Intergene Biosciences is an active private limited company based in Bangalore, Karnataka, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 06 April 2021 (5+ years old) and is registered under CIN U24230KA2021PTC146156.
Intergene Biosciences has 3 current directors:
- Ganessin Aravind - Director
- Uma Thiagarajan - Director
- Aniruddha Maram - Director
The latest financial statements of Intergene Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Intergene Biosciences is U24230KA2021PTC146156. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Intergene Biosciences was incorporated on 06 April 2021, making it 5+ years old. It is registered with the Registrar of Companies, Bangalore.
Aniruddha Maram was appointed as Director on 25 Apr 2024. Ganessin Aravind was appointed as Director on 06 Apr 2021. Uma Thiagarajan was appointed as Director on 06 Apr 2021.
Yes, Intergene Biosciences is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Intergene Biosciences is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0074828).
The registered office of Intergene Biosciences is at No. 210 Second Floor I Phase I Main Road Kengeri Satellite Town, Bangalore, Karnataka, India – 560060.
Intergene Biosciences operates in the chemicals industry, in the manufacturing segment.